Navigation Links
Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile
Date:5/9/2008

TAMPA, Fla., May 9 /PRNewswire-USNewswire/ -- Osteoarthritis is a painful and potentially debilitating condition that affects almost 50 million people in the United States. It is caused by deterioration of cartilage in bone joints. The novel investigational pain medication tapentadol, a centrally acting oral analgesic, provided significant relief for patients with joint-disease pain, compared to those treated with placebo, and with fewer gastrointestinal side effects than those treated with an older, prescription pain reliever, researchers announced today.

Results from a Phase 3 clinical study of tapentadol immediate release (IR) tablets showed that patients treated with a 50 mg or 75 mg dose of tapentadol experienced significant relief in end-stage joint disease pain compared to placebo (P<0.001) when assessed over five days of treatment. In addition, patients treated with tapentadol experienced significantly better digestive tract tolerability compared to patients treated with 10 mg of oxycodone IR. Digestive tract tolerability is one of the leading causes of treatment discontinuation for patients who take prescription pain medications.

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) presented these new data in a poster session at the 27th Annual Scientific Meeting of the American Pain Society (APS) in Tampa, Florida.

Tapentadol has a unique profile with two mechanisms of action, combining mu-opioid receptor agonism and norepinephrine reuptake inhibition in a single molecule. It is being developed in immediate-release formulation for acute pain and extended-release formulation for chronic pain.

Mu-opioid agonists are drugs that bind to and activate mu-opioid receptors in the central nervous system. These drugs modify sensory and affective (mood) aspects of pain, inhibit the transmission of pain at the spinal cord and affect activity at parts of the brain that control how pain is perceived. Nor
'/>"/>

SOURCE Johnson & Johnson Pharmaceutical Research & Development,L.L.C.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
4. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
5. Tapestry Reports Second Quarter 2007 Results
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
9. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... Sept. 3,  2015 About artificial ... devices, which are implanted or integrated into ... These include artificial heart, kidney, pancreas, and ... (polyurethane, polysulfone, and porous polypropylene), biologics, ceramics, ... organs. These organs are incorporated with different ...
(Date:9/3/2015)... 3, 2015 This Defibrillators are critical life ... of lives across globe. This report provides in-depth analysis ... Saudi Arabia . Stakeholders for this report include ... and regulatory bodies. The Saudi Arabia ... by products and by end users. In terms of ...
(Date:9/3/2015)... 3, 2015 Nevro Corp. (NYSE: NVRO ... innovative evidence-based solutions for the treatment of chronic pain, ... the Morgan Stanley Global Healthcare Conference on Thursday, September ... Nevro management is scheduled to present at 11:45 a.m. ... audio webcast, accessible in the "Investors" section of the ...
Breaking Medicine Technology:Global Artificial Organ Market 2015-2019 2Saudi Arabia Defibrillators Market: & Advanced Life Support Defibrillators; End Users; Industry Analysis, Size, Volume, Growth, Trends and Forecast 2014 - 2020 2
... LAGUNA HILLS, Calif., Sept. 30 Minnow Medical, Inc., ... thermoplasty for the treatment of in-stent restenosis and other ... executive Raymond W. Cohen has been named chief executive ... Cohen, 51, has more than 25 ...
... Ohio, Sept. 30 Although last year,s flu season ... illness and associated vaccine shortages, pharmacy experts at Cardinal ... for the 2010-2011 flu season. The upcoming ... federal government,s Advisory Committee on Immunization Practices (ACIP) has ...
Cached Medicine Technology:Minnow Medical Names Raymond W. Cohen as Chief Executive Officer 2Cardinal Health Helps Health Care Providers Prepare for 2010-2011 Flu Season 2Cardinal Health Helps Health Care Providers Prepare for 2010-2011 Flu Season 3Cardinal Health Helps Health Care Providers Prepare for 2010-2011 Flu Season 4
(Date:9/4/2015)... ... September 04, 2015 , ... ... Residence in South Glastonbury, Connecticut, has been selected for the Residential Award of ... energy efficiency and resiliency measures. Chosen from a highly competitive field of submissions, ...
(Date:9/4/2015)... ... ... Pastor and Overseer at The House of Yahweh, has written an open letter to Pope ... the United States. , Yisrayl lays out what he says is the true meaning of ... also provides the meaning of his own name and describes what bible prophecy says about ...
(Date:9/4/2015)... ... September 04, 2015 , ... EMED Jamaica Global Ltd. ... it has entered into a multi-year agreement with Health City Cayman Islands. , ... link between American healthcare, Jamaican healthcare and Health City Cayman Islands to deliver ...
(Date:9/3/2015)... ... 04, 2015 , ... AlignLife of Wauwatosa is excited to hold ... many children and adults who don't have the ability to buy a jacket warm ... our annual Coat Drive to help those in need." , This is AlignLife's third ...
(Date:9/3/2015)... ... ... Allied Anesthesia is proud to announce a continuing partnership with St. Jude ... St. Jude was recently named one of the nation’s top stroke centers by The ... 10 hospitals in the state to earn the distinction. , The chances of ...
Breaking Medicine News(10 mins):Health News:South Glastonbury Home Selected for Award by Connecticut Green Building Council 2Health News:Yisrayl Hawkins Writes Open Letter to Pope Francis In Light of Approaching U.S. Visit 2Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 2Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 3Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 4Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 5Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 6Health News:AlignLife is Helping to Keep the Community Warm This Winter 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 3
... from exposure to medications, chemicals and other agentsSAN DIEGO, ... taking cold medication or using certain cleaning products can ... A new Web site ( www.ctispregnancy.org ) ... latest information about the potential risks of exposure to ...
... restore sight, experts suggest , , THURSDAY, March 5 (HealthDay ... in two forms of childhood blindness has been identified ... of the link between the retinal gene SPATA7 and ... because it pinpoints a new retinal metabolic disease pathway ...
... 100 property and casualty insurers closed 2008 with net ... while the top 100 life insurers suffered unprecedented unrealized ... 2008 Top 100 Performance Monitor revealed a 67.7 percent ... industry,s top property and casualty insurers, from $48.8 billion ...
... Americas, Europe and Asia to Realize New Executive ... Tokyo Stock Exchange), a leading medical diagnostics ... announced executive leadership changes at Sysmex Corporate and ... Effective April 1, 2009, Kazuya Obe will ...
... stroke and heart disease are potential complications of type ... Americans. Now research from Tel Aviv University has found ... a risk factor accelerating cognitive decline and dementia. ... TAU,s Sackler School of Medicine, found that people with ...
... 2009 Many doctors don,t offer emergency contraception ... during emergency department visits because of misinformation about ... by The Children,s Hospital of Philadelphia. , ... reduce unintended pregnancy, the study,s authors said. ...
Cached Medicine News:Health News:New Online Service Helps Expectant Moms 2Health News:Retinal Gene Is Linked to Childhood Blindness 2Health News:Highline Data Analysis Shows Year-over-Year P&C Industry Net Income Down 67.7%, Life Industry Net Unrealized Capital Losses Totaled $51.7 billion in 2008 2Health News:Highline Data Analysis Shows Year-over-Year P&C Industry Net Income Down 67.7%, Life Industry Net Unrealized Capital Losses Totaled $51.7 billion in 2008 3Health News:Sysmex Corporation Announces Organizational Changes 2Health News:New Tel Aviv University research links diabetes to cognitive deterioration 2Health News:Education may improve hospital prescription rate of emergency contraception to teens 2
... Cryo-Star - a vision becomes reality. ... offer the users many benefits.,The Cryo-Star ... with retraction that incorporates a unique ... knife cooling. This facilitates applications in ...
... 120 represents a new tissue infiltration instrument, ... a masterly way. The robust caroussel design ... smallest space. The instrument includes either 10 ... reagent and 3 paraffin containers. Up to ...
... concept in a power assisted microtome combines ... Power assisted horizontal movements are proportionally related ... knife edge. Duplicate controls provide for convenient ... while the operating levers and handles may ...
... new face-lifted Leica RM2125 microtome comes in ... and Leica RM2125 RT. All RM2125 versions ... avoid debris entering the precision micrometer feeding ... a two-step trimming function and specimen retraction ...
Medicine Products: